Get our E-Alerts
Articles ▼ All Issues About Us ▼ Submit Manuscript Get our E-Alerts
Review Article
06 Aug 2025
Beyond Benzoyl Peroxide: The New Landscape of Over-the-counter Therapies for Acne
Yeanna Moon, B.A., Peter Lio, M.D.
Review Article
06 Nov 2025
Beyond Benzoyl Peroxide: The New Landscape of Over-the-counter Therapies for Acne
Yeanna Moon, B.A., Peter Lio, M.D.
DOI:
10.64550/joid.2gybwa46
Reviewed by:
Jennifer Ornelas, MD, Natalie Yin, MD
Abstract

Acne vulgaris is a prevalent dermatological condition that primarily affects the pilosebaceous units, leading to comedones, papules, pustules, and nodules.^1^ This condition affects approximately 9.4% of the global population, making it the eighth most common disease worldwide.^2^ It predominantly affects adolescents and young adults, with a significant psychosocial impact, including diminished self-esteem and increased risk of depression.^2^ Traditionally, over-the-counter (OTC) treatments have been limited to agents like benzoyl peroxide and salicylic acid. However, recent advancements have introduced a variety of novel OTC therapies including topical probiotics and concentrated oxygen therapies which are gaining attention. Given the expanding array of OTC options and their accessibility, a comprehensive review of current therapies is essential to guide evidence-based clinical recommendations.

To evaluate the efficacy and safety profiles of established and emerging OTC acne treatments, PubMed, Embase, and the Cochrane Library searches were conducted with terms included “acne vulgaris,” “over-the-counter treatments,” “topical therapies,” and specific agents.

Many OTC acne therapies show antimicrobial and anti-inflammatory effects in vitro and small clinical trials. Established agents like adapalene and benzoyl peroxide had the strongest clinical evidence. Emerging options such as phage therapy and probiotics are promising but require further validation.

OTC acne treatments continue to diversify, offering new options beyond legacy therapies. While some newer agents are mechanistically compelling, high-quality studies are needed to define their role in acne management.

Introduction

Acne vulgaris is a prevalent chronic inflammatory skin condition that primarily affects the pilosebaceous units, leading to various lesions such as comedones, papules, pustules, and nodules.1 It is most common during adolescence and young adulthood, with a global prevalence estimated at approximately 9.4%, making it the eighth most prevalent disease worldwide.2 Its pathogenesis involves a complex interplay of hormonal, microbial, immunological, and environmental factors.3

Over the counter (OTC) treatments have traditionally included agents such as benzoyl peroxide, salicylic acid, and topical retinoids like adapalene. While these treatments are effective for many individuals, concerns exist regarding potential side effects, including skin irritation and dryness. Additionally, the emergence of antibiotic resistance has prompted the exploration of alternative therapies.

Emerging therapies aim to address these concerns by targeting different aspects of acne pathogenesis. These include topical probiotics to modulate the skin microbiome, bacteriophage therapy targeting Cutibacterium acnes, and light-based treatments that reduce bacterial colonization and inflammation. Such innovations offer promising alternatives, especially for individuals who experience side effects from traditional therapies or have antibiotic-resistant acne strains.

A literature review was conducted using databases including PubMed, Embase, and the Cochrane Library. Search terms encompassed “acne vulgaris,” “over-the-counter treatments,” “topical therapies,” and specific agents. Inclusion criteria comprised randomized controlled trials, meta-analyses, and observational studies evaluating the efficacy and safety of OTC acne treatments. Data extraction emphasized treatment outcomes, adverse effects, and patient satisfaction.

Core OTC Acne Treatments
I. Adapalene (retinoid)

Adapalene is a third-generation topical retinoid available in 0.1% and 0.3% concentrations, primarily used to treat mild to moderate acne vulgaris. It works by modulating keratinocyte differentiation and proliferation, preventing microcomedone formation, and it exhibits anti-inflammatory properties by inhibiting inflammatory mediators.4 Common side effects include skin irritation, dryness, redness, and a transient burning or stinging sensation, particularly during the initial weeks of therapy.4 Adapalene is contraindicated during pregnancy due to potential teratogenic risks associated with retinoids.5 (Please see Table 1)

304119 Over-the-counter Therapies for Acne.

Drug Dose Mode of Action Clinical Evidence Adverse effects Approval/Regulatory Status References
Adapalene (retinoid) 0.1%–0.3% Anti comedogenic effect, indirect antimicrobiotic effect Mild to moderatecomedonal acne Irritation, contraindicated in pregnant women FDA Approved 4, 5
Azelaic acid (Keratolytics) 20% Anticomedogenic and antimicrobial effect, reduces the production of keratohyalin granules in the pilosebaceous duct and thus normalizes the ductal hypercornification; keratolytic and anti-inflammatory Mild to moderate acne Only a slight sensation of burning or tingling, mild erythema FDA Approved 7, 8
Benzoyl peroxide (Keratolytics) 1%–10% Antimicrobial effect (reactive oxygen species are generated that kill bacteria by oxidizing constituents of their cell membranes), antiinflammatory, very mild anti comedogenic effects, keratolytic Inflammatory acne, Mild to moderate acne Irritant dermatitis with erythema and scaling, dryness, peeling, stinging, or burning, bleach hair, clothes, and bed linens FDA Approved 9, 10
Salicylic acid (Keratolytics) 0.5-2% Anti-inflammatory, topical desquamating agent, comedolytic Comedonal acne Skin irritation and dryness FDA Approved 11, 12, 13
Sulfur (Keratolytics) 1–10% Keratolytic activity Mild to moderate acne Malodor and dry skin FDA Approved 14
Zinc (Keratolytics) 200 mg/day (Zn gluconate), 400 or 600 mg/day (Zn sulfate) Bacteriostatic, inhibits chemotaxis, and may decrease tumor necrosis factor—α production Mild or moderate acne, severe and inflammatory acne Nausea, vomiting, and diarrhea with gastrointestinal side effects FDA has approved zinc oxide for use in some over-the-counter skin products like sunscreens and skin protectants 11, 15
Alpha hydroxyl acids (Glycolic and lactic acid) (Keratolytics) 10% Exfoliative capabilities, promotes epidermolysis, disperse basal layer melanin, increases collagen synthesis within the dermis Mild Acne Redness, swelling, burning, and pruritus FDA-approved for use in cosmetic products 16, 17
Sodium sulfacetamide (Keratolytics) 10% with 5% sulphur Inhibiting C. acnes proliferation, act through competitive antagonism of para-aminobenzoic acid, halting bacterial DNA synthesis Inflammatory lesions and comedones Mild transient dryness, itching Available OTC; not FDA-approved for acne treatment. 11, 18
Niacinamide 2–5% Anti-inflammatory properties; reduces sebum production; improves skin barrier function. Mild to moderate acne vulgaris Generally well-tolerated; rare cases of skin irritation Available OTC; not FDA-approved specifically for acne treatment. 19
Resorcinol (with Sulfur) Commonly 2% resorcinol with 8% sulfur in topical preparations. Keratolytic agent; helps remove skin cell buildup; sulfur component has antibacterial properties. Mild to moderate acne Skin irritation, redness, peeling Available OTC; not FDA-approved specifically for acne treatment. 11, 14, 20
Hydrocolloid Patches Typically contain no active ingredients. Occlusive dressing; absorbs excess fluid; protects blemish from external irritants. Pustules Minimal; potential for skin irritation if adhesive is too strong Available OTC; not FDA-approved specifically for acne treatment. 21
Blue Light Therapy (LED Devices) 400-500 nm Light in the 407-420 nm wavelength range has been shown to have a bactericidal effect on C. acnes Mild to moderate inflammatory acne Mild but can include skin irritation, erythema, dryness, tightness, rashes, peeling, itching, burning, acne flare-ups, changes in pigmentation FDA has approved light-emitting diode (LED) devices (blue, red, and blue/red light devices) for at-home use 22
Melaleuca alternifolia (tea tree oil) 1-100% In tea tree oil, terpinen-4-o1, α-terpineol, and α-pinene were found to be active against S. aureus, S. epidermidis, and C. acnes Mild and Cystic Acne Can induce allergic contact dermatitis. It has been proposed that photo-oxidized products from poor storage conditions are the cause of allergic reactions Generally recognized as safe (GRAS) by FDA 23, 24
Rosemary essential oil Commonly used in diluted topical formulations. Antibacterial against C. acnes (MIC 0.56 mg/mL) was probably attributed to its bioactive components such as 1,8-cineole, α-pinene, camphor, and camphene. Mild to Moderate Acne Can induce allergic contact dermatitis Generally recognized as safe (GRAS) by FDA 25, 26
Green Tea Extract (Camellia sinensis L) 3% Antioxidant and anti-inflammatory properties; may reduce sebum production and inflammation. Mild to moderate acne May induce allergic contact dermatitis Available OTC; not FDA-approved specifically for acne treatment. 27, 28
Clays (Kaolin, Bentonite) Used in facial masks and cleansers. Absorb excess oil; may help unclog pores. Mild acne Skin dryness, irritation Available OTC; not FDA-approved specifically for acne treatment. 29, 30
Witch Hazel (Hamamelis virginiana) 5% to 10% Astringent and anti-inflammatory properties; may reduce oiliness and inflammation. Mild acne Skin Inflammation Available OTC; not FDA-approved specifically for acne treatment. 31, 32
Retinol / Retinyl Palmitate 0.01% to 1% Promotes cell turnover and prevents pore clogging. Mild to moderate acne Skin irritation, dryness, photosensitivity Available OTC; not FDA-approved specifically for acne treatment. 33
Manuka Honey Varies Antimicrobial properties due to methylglyoxal content; promotes wound healing. Mild acne Rare allergic reactions Available OTC; not FDA-approved specifically for acne treatment. 34
Microneedle Patches (with Salicylic Acid, Niacinamide, etc) Varies; typically used as a single-use patch. Microneedles deliver active ingredients directly into the skin; salicylic acid exfoliates, niacinamide reduces inflammation. Localized acne lesions Skin irritation, redness Available OTC; not FDA-approved specifically for acne treatment. 35
C. Phage Phages can selectively kill C. acnes, particularly type I strains, and may restore bacterial sensitivity to antibiotics by targeting multidrug efflux pumps, which act as phage receptors Mild to Moderate Acne Pro-inflammatory responses to phages, in which cytokines such as TNFα, IL-1β, IL-6, and IL-17A were reported Available OTC; not FDA-approved specifically for acne treatment. 36, 37
Topical nitric oxide and its derivatives (NO4% gel) Concentrations vary; specific formulations under investigation NO-releasing nanoparticles exhibit remarkable bactericidal activity against C. acnes, effectively inhibiting its growth and suppressing the release of cytokines such as TNF-α, IL-1β, IL-6, and IL-8 in human cells Mild to Moderate Acne Nasopharyngitis, Headache, Dysmenorrhea Available OTC; not FDA-approved specifically for acne treatment. 38, 39
Oxygen Therapy OTC oxygenated water available, but typically administered in medical spa settings. Oxygen antibacterial action is primarily due to the generation of reactive oxygen species (ROS), which damage microbial membranes and kill pathogens. Additionally, oxygen enhances wound healing and neoangiogenesis by stimulating the release of vascular endothelial growth factor (VEGF) and related factors. Mild to Moderate Acne None Reported Not FDA-approved for acne treatment; used in clinical settings. 40, 41, 42
Probiotics / Postbiotics (Topical) Varies; concentrations not standardized. Microorganisms from the skin can act directly to defend the host against pathogens, control inflammation, and modulate the adaptive immune pathways Mild to moderate acne Antibiotic resistance transfer among pathogens, allergic reactions, and bacteremia Available OTC; not FDA-approved specifically for acne treatment. 43-45
Bakuchiol (Psoralea corylifolia) Varies; concentrations not standardized. Anti-aging, anti-inflammatory, and antibacterial properties Mild to moderate acne Contact dermatitis Available OTC; not FDA-approved specifically for acne treatment. 46, 47
Topical CBD / Cannabinoids Concentrations vary; typically 1–5% in topical formulations. By inhibiting intracellular adenosine uptake, CBD promotes endogenous adenosine signaling as a protective mechanism during inflammatory and immune response. Mild to moderate acne Not well-studied; potential for skin irritation Not FDA-approved for acne treatment; available in some OTC products. 48-50
Apple Cider Vinegar (ACV) Typically diluted to 5–10% for topical use. Vinegar (and other weak acids) induces a stress response in yeast cells by lowering their pH Mild acne Burns, (especially in children) and contact dermatitis to nickel, as vinegar increases the leaching of nickel storage containers leading to a higher nickel content. Not FDA-approved for acne treatment; available OTC. 51

Initially approved by the U.S. Food and Drug Administration (FDA) as a prescription medication, adapalene 0.1% gel became the first retinoid approved for OTC use in 2016 for individuals aged 12 years and older.6

II. Azelaic acid

Azelaic acid is a naturally occurring dicarboxylic acid utilized topically at a 20% concentration for the treatment of mild to moderate acne vulgaris.7 Its mechanism of action includes antimicrobial activity against C. acnes, anti-inflammatory effects through the inhibition of reactive oxygen species, and normalization of keratinization by reducing the production of keratohyalin granules in the pilosebaceous duct.7 Common adverse effects are generally mild and transient, including burning, stinging, tingling, dryness, and redness at the application site.7

The U.S. FDA approved azelaic acid 20% cream in 1995 for the topical treatment of mild to moderate inflammatory acne vulgaris.8

III. Benzoyl peroxide

Benzoyl peroxide (BPO) is a widely utilized over-the-counter topical agent for the treatment of acne vulgaris, particularly effective against mild to moderate forms. Available in concentrations ranging from 1% to 10%, BPO exhibits multiple mechanisms of action. Primarily, it serves as a potent antimicrobial by releasing reactive oxygen species that oxidize bacterial proteins, effectively reducing C. acnes populations.9 Additionally, BPO possesses keratolytic properties, promoting the desquamation of the follicular epithelium, which aids in preventing comedo formation.9 Its mild anti-inflammatory effects further contribute to its efficacy in acne management.9 Common adverse effects associated with BPO include skin irritation, dryness, peeling, redness, and a burning or stinging sensation at the application site. Notably, BPO has a bleaching effect, which can discolor hair, clothing, and bedding upon contact.9

The U.S. FDA has approved benzoyl peroxide for over-the-counter use in acne treatment products. However, recent testing has identified elevated levels of benzene, a known carcinogen, in a small number of BPO-containing products, leading to voluntary recalls of those specific items.10

IV. Salicylic acid

Salicylic acid is a beta-hydroxy acid that penetrates the skin to exfoliate and unclog pores, making it effective against comedonal acne.11 It also exhibits anti-inflammatory properties by suppressing the NF-κB pathway, reducing inflammation associated with acne lesions.12 Common side effects include skin irritation and dryness.11 The U.S. FDA has approved salicylic acid for over-the-counter use in acne treatment products.13

V. Sulfur

Sulfur is applied topically in concentrations between 1% and 10%, exhibits keratolytic and antibacterial properties, aiding in the treatment of mild to moderate acne.14 It helps to shed dead skin cells and reduce excess oil, preventing pore blockage.14 Adverse effects may include malodor and dry skin.14 Sulfur is FDA-approved for acne treatment.

VI. Zinc

Zinc, administered orally as zinc gluconate (200 mg/day) or zinc sulfate (400–600 mg/day), has bacteriostatic properties and inhibits chemotaxis, potentially reducing tumor necrosis factor-alpha production.15 It is used for mild to moderate acne and may be beneficial in severe inflammatory cases.11 Side effects can include gastrointestinal disturbances such as nausea, vomiting, and diarrhea.11 While zinc oxide is FDA-approved for use in over-the-counter skin products like sunscreens and skin protectants, oral zinc supplements are not specifically approved for acne treatment.

VII. Alpha hydroxy acids (AHAs)

Alpha hydroxy acids (AHAs), such as glycolic and lactic acids, are typically used at concentrations around 10% for their exfoliative capabilities.16 They promote epidermolysis, disperse basal layer melanin, and increase collagen synthesis within the dermis, aiding in the treatment of mild acne. Adverse effects may include redness, swelling, burning, and pruritus.16 AHAs are FDA-approved for use in cosmetic products.17

VIII. Sodium sulfacetamide

Sodium sulfacetamide, often combined with 5% sulfur, acts by inhibiting C. acnes proliferation through competitive antagonism of para-aminobenzoic acid, halting bacterial DNA synthesis.18 It is effective for inflammatory lesions and comedones.11 Side effects can include mild transient dryness and itching.11 While this combination is not technically FDA-approved for acne treatment, the presence of sulfur allows for labeling as such.

IX. Niacinamide

Niacinamide, applied topically in concentrations of 2–5%, possesses anti-inflammatory properties, reduces sebum production, and improves skin barrier function.19 It is effective for mild to moderate acne vulgaris.11 Generally well-tolerated, rare cases of skin irritation have been reported.11 Niacinamide is available OTC but is not FDA-approved specifically for acne treatment.

X. Resorcinol

Resorcinol combined with sulfur is a topical acne treatment commonly formulated with 2% resorcinol and 8% sulfur. Resorcinol functions as a keratolytic agent, promoting the shedding of the outer skin layer to prevent pore blockage and reduce comedo formation.20 It also exhibits antimicrobial properties, contributing to its effectiveness against acne-causing bacteria.20 Sulfur complements this action by further aiding in the removal of dead skin cells and absorbing excess oil, thereby reducing the likelihood of clogged pores.14 This combination is particularly effective for treating mild to moderate acne, including blackheads and whiteheads.11 Common side effects may include skin irritation, redness, peeling, and dryness.20 These effects are generally mild and can often be managed by adjusting the frequency of application. Resorcinol-sulfur formulations are available over the counter in various forms, such as creams and lotions, but they are not specifically approved by the FDA for acne treatment.

XI. Hydrocolloid patches

Hydrocolloid patches are non-medicated, adhesive dressings originally developed for wound care but have gained popularity for managing superficial acne lesions. These patches are composed of hydrocolloid material that absorbs excess fluid from pimples, creating a moist environment that promotes faster healing. At the same time, the patches protect the area from external contaminants and physical irritation while concealing the acne lesion.21 By maintaining this occlusive barrier, hydrocolloid patches can help reduce inflammation and prevent further infection.21 Some hydrocolloid patches are infused with active ingredients like salicylic acid or tea tree oil to enhance their acne-fighting properties, but the primary mechanism remains fluid absorption and protection. Adverse effects are minimal but can include skin irritation, especially in individuals with sensitive skin or when the adhesive is too strong.21

Hydrocolloid patches are widely available over the counter and are generally recognized as safe for use; however, they are not specifically approved by the FDA for acne treatment.

XII. Blue Light Therapy

Blue light therapy, utilizing wavelengths between 405 and 420 nanometers, is a non-invasive treatment for mild to moderate inflammatory acne.22 It works via targeting C. acnes. These bacteria produce porphyrins, which, when exposed to blue light, generate reactive oxygen species that destroy the bacterial cells.22 Additionally, blue light may exert anti-inflammatory effects by modulating cytokine production, thereby reducing inflammation associated with acne lesions.22

FDA-approved blue light therapy devices are available for at-home use, offering a convenient, non-pharmacologic option for individuals seeking alternative or adjunctive acne treatments. While generally well-tolerated, potential side effects include skin irritation, redness, dryness, and, in rare cases, changes in pigmentation.22 The FDA has approved light-emitting diode (LED) devices (blue, red, and combination light devices) for at-home use.

Adjunct or Cosmeceutical Therapy
XIII. Tea Tree Oil (Melaleuca alternifolia)

Melaleuca alternifolia, commonly known as tea tree oil, is an essential oil derived from the leaves of the Australian tea tree. It is widely recognized for its antimicrobial and anti-inflammatory properties, making it a popular OTC remedy for mild to moderate acne, including cystic lesions. The primary active component, terpinen-4-ol, exhibits broad-spectrum antibacterial activity, effectively targeting acne-causing bacteria such as C. acnes and Staphylococcus aureus.23 Additionally, tea tree oil has been shown to reduce inflammation, which can help alleviate the redness and swelling associated with acne lesions.23 However, side effects include skin irritation in some individuals, and allergic contact dermatitis has been reported.23 To minimize the risk of adverse reactions, it’s recommended to perform a patch test before applying tea tree oil to larger areas of the skin.

Tea tree oil is generally recognized as safe (GRAS) by the U.S. FDA for topical use, but it is not specifically approved for acne treatment. It is available in various formulations, including pure essential oils, gels, creams, and cleansers.

XIV. Rosemary essential oil

Rosemary essential oil, derived from the leaves of Rosmarinus officinalis, has garnered attention for its potential benefits in acne management. Its efficacy is primarily attributed to bioactive constituents such as 1,8-cineole, α-pinene, camphor, and camphene, which exhibit significant antibacterial activity against C. acnes.24 Studies have demonstrated that rosemary essential oil can disrupt the bacterial cell wall and membrane, leading to cell death.24 Beyond its antimicrobial effects, rosemary essential oil possesses anti-inflammatory properties that may alleviate the redness and swelling associated with acne lesions.24 These combined actions suggest its utility in treating mild to moderate acne. Despite its potential benefits, rosemary essential oil can cause allergic contact dermatitis in some individuals.25

While rosemary essential oil is generally recognized as safe (GRAS) by the U.S. Food and Drug Administration for use in food, it is not specifically approved for acne treatment.

XV. Green tea extract (EGCG)

Green tea extract, derived from the leaves of Camellia sinensis, has garnered attention for its potential benefits in managing mild to moderate acne. Rich in polyphenolic compounds, particularly epigallocatechin-3-gallate (EGCG), green tea exhibits notable antioxidant and anti-inflammatory properties.26 The antibacterial effects of green tea extract further enhance its role in acne management.26 EGCG has been shown to inhibit the growth of C. acnes by disrupting bacterial membranes and reducing pro-inflammatory cytokine production.27 Moreover, green tea’s antioxidant capacity helps protect the skin from oxidative stress, which can exacerbate acne.26

Green tea extract is available over the counter in various formulations, including creams, lotions, and cleansers. Although it is not specifically approved by the FDA for acne treatment, it is recognized as safe for use in cosmetic products.

XVI. Clays (kaolin, bentonite)

Kaolin and bentonite clays are natural minerals widely used in OTC skincare products, particularly facial masks and cleansers, for managing mild acne. Kaolin, a hydrated aluminum silicate, is known for its gentle absorbent properties, making it suitable for sensitive skin.28 Bentonite, primarily composed of montmorillonite, exhibits strong absorptive capabilities due to its negative charge, allowing it to attract and remove positively charged toxins, bacteria, and excess oils from the skin.29 Clinical studies have demonstrated that masks containing these clays can significantly reduce sebum production, decrease the number of open and closed comedones, and improve overall skin texture.28 However, potential adverse effects include skin dryness and irritation, particularly with overuse or in individuals with naturally dry or sensitive skin.

While kaolin and bentonite clays are GRAS for topical use, they are not specifically approved by the FDA for acne treatment.

XVII. Witch hazel (Hamamelis virginiana)

Witch hazel (Hamamelis virginiana) is a botanical extract commonly incorporated into OTC skincare products, particularly toners and astringents, aimed at managing mild acne. Its efficacy is primarily attributed to its rich content of tannins and flavonoids, which confer astringent and anti-inflammatory properties.30 These compounds help reduce skin oiliness by constricting pores and diminishing inflammation, potentially alleviating acne symptoms.30 Despite its widespread use, witch hazel may cause adverse effects such as skin irritation, dryness, or allergic contact dermatitis, particularly in those with sensitive skin.31 These reactions may be exacerbated by formulations containing alcohol, which is often present in witch hazel extracts and can further dry out the skin.

While witch hazel is GRAS for topical use and is available over the counter, it is not specifically approved by the U.S. FDA for acne treatment.

XVIII. Retinol/Retinyl palmitate

Retinol and retinyl palmitate are vitamin A derivatives commonly found in OTC acne products at concentrations ranging from 0.01% to 1%. These ingredients promote epidermal cell turnover and prevent clogged pores, targeting key steps in acne pathogenesis.32 Retinol converts into retinoic acid in the skin, while retinyl palmitate acts as a gentler precursor, making it better suited for sensitive skin.32

Though not FDA-approved specifically for acne, both are widely used in mild to moderate cases.

XIX. Manuka honey

Manuka honey, derived from the Leptospermum scoparium plant, is increasingly used in skincare for its natural antimicrobial and wound-healing properties.33 Its efficacy in acne treatment is primarily attributed to methylglyoxal (MGO), a compound with strong antibacterial activity against C. acnes and Staphylococcus aureus.33 It also maintains a moist wound environment and has anti-inflammatory effects, which may help reduce redness and swelling associated with mild acne.

Though available over the counter and marketed for various skin concerns, Manuka honey is not FDA-approved specifically for acne treatment.

XX. Microneedle patches

Microneedle patches are emerging OTC acne treatments designed to deliver active ingredients, commonly salicylic acid and niacinamide, directly into the epidermis through tiny, dissolvable needles. This targeted delivery allows deeper penetration compared to traditional topicals, enhancing the effectiveness of exfoliants like salicylic acid and anti-inflammatory agents like niacinamide.34 These patches are typically used as single-use spot treatments for localized acne lesions, particularly papules and pustules. However, mild side effects such as redness, irritation, or transient discomfort at the application site may occur.24

Though available OTC and widely marketed in cosmeceuticals, these devices are not FDA-approved specifically for acne treatment.

Emerging Therapies
XXI. C. Phage (bacteriophage therapy)

C. acnes bacteriophage therapy is an emerging approach in acne treatment that utilizes viruses (phages) capable of selectively infecting and lysing C. acnes, especially type I strains associated with acne pathogenesis.35 Phages can also help reverse bacterial resistance by targeting multidrug efflux pumps that serve as phage receptors, potentially restoring antibiotic sensitivity.35 Some bacteriophages show long-term stability, especially when formulated with appropriate stabilizers or in semisolid vehicles, but they generally require refrigeration and optimized buffer conditions to maintain efficacy. Some products are already available as over-the-counter preparations. This therapy has shown promise for mild to moderate acne, as it directly modulates the skin microbiome without harming commensal organisms.

Although bacteriophage therapy is promising and is being incorporated into skincare regimens, much remains to be elucidated and there is no FDA-approved product in this category for acne at this time.

XXII. Topical nitric oxide / NO-releasing agents

Topical nitric oxide (NO) therapies, particularly formulations like NO 4% gel, represent an innovative approach to acne treatment through controlled nitric oxide release. NO-releasing nanoparticles have demonstrated strong antimicrobial activity against C. acnes, significantly reducing bacterial viability.36 In addition to their bactericidal effects, these agents also suppress pro-inflammatory cytokines, including TNF-α, IL-1β, IL-6, and IL-8, thereby addressing both microbial and inflammatory components of acne pathophysiology.36

Clinical studies have shown efficacy in patients with mild to moderate acne, with reductions in lesion counts and inflammatory markers. Reported adverse effects include nasopharyngitis, headache, and dysmenorrhea.37

Although topical nitric oxide is available in some OTC formulations and as cosmeceuticals, these agents are not yet FDA-approved for acne.

XXIII. Oxygen therapy

Oxygen therapy for acne is a non-invasive treatment typically administered in medical spas or clinical settings rather than through OTC products. Its proposed mechanism involves the generation of reactive oxygen species (ROS), which exert potent antimicrobial effects by disrupting microbial membranes, including those of C. acnes.38 Additionally, oxygen therapy promotes wound healing and skin rejuvenation by stimulating angiogenesis through the upregulation of vascular endothelial growth factor (VEGF) and other pro-healing cytokines.39 This therapy is generally marketed for mild to moderate inflammatory acne and is often combined with other facial treatments.

Some newer topical formulations use oxygen and carbon dioxide in nanobubble suspensions to enhance transdermal gas absorption. These nanobubbles are taken up by the skin’s outer layers, where carbon dioxide promotes local vasodilation, improving blood flow and tissue oxygenation via the Bohr effect, while oxygen supports cellular repair and antimicrobial activity.40

While adverse effects are rare and generally unreported, its clinical efficacy remains under investigation, and it has not received FDA approval specifically for acne treatment.

XXIV. Probiotics/Parabiotics/Postbiotics (topical)

Topical probiotics and postbiotics are emerging as promising adjunctive treatments for mild to moderate acne. Various formulations typically contain live or lysed commensal bacteria or their metabolites, designed to restore skin microbiome balance, suppress C. acnes overgrowth, and reduce inflammation. Key mechanisms include enhancing barrier function, producing antimicrobial peptides, and modulating both innate and adaptive immune responses.41

While this category of therapy is generally considered safe, concerns include the potential for allergic reactions, antibiotic resistance gene transfer, and, though rare, bacteremia particularly in immunocompromised individuals.42,43

There are a number of these products available OTC but none are FDA-approved specifically for acne.

XXV. Bakuchiol (retinol alternative)

Bakuchiol is a plant-derived compound extracted from Psoralea corylifolia and is gaining popularity as a botanical alternative to retinoids in acne management. It exhibits anti-inflammatory, antibacterial, and antioxidant properties that contribute to its efficacy in treating mild to moderate acne.44 Mechanistically, bakuchiol downregulates C. acnes proliferation and inhibits inflammatory pathways involved in acne pathogenesis, including NF-κB signaling.44

Although structurally distinct from retinoids, bakuchiol mimics many of their effects, such as promoting cell turnover and reducing hyper keratinization, but with fewer reports of irritation or photosensitivity.45 It also has demonstrated effectiveness in reducing hyperpigmentation and fine lines, making it a popular dual-purpose ingredient in acne and anti-aging regimens.44 Bakuchiol is available OTC in various cosmetic formulations, but concentrations are not standardized across products. The most common adverse effect reported is allergic contact dermatitis, though this remains relatively rare. While promising, bakuchiol is not FDA-approved specifically for the treatment of acne.

XXVI. Topical CBD / Cannabinoids

Topical cannabidiol (CBD), a non-psychoactive phytocannabinoid derived from Cannabis sativa, has emerged as a novel anti-inflammatory and sebostatic agent for acne. Its therapeutic potential is primarily attributed to its ability to inhibit intracellular adenosine uptake, which enhances endogenous adenosine signaling, a known pathway involved in reducing inflammation.46 Additionally, CBD modulates the activity of sebaceous glands, decreasing sebum production and limiting the proliferation of C. acnes, thereby addressing key pathogenic mechanisms in acne development.47 Formulations typically contain 1–5% CBD, though standardized concentrations are lacking across OTC products. While generally well-tolerated, reports of cannabinoid abuse accompanied by acne have been noted.48

Despite increasing commercial availability in OTC skincare, topical CBD is not FDA-approved for acne treatment.

XXVII. Apple cider vinegar

Apple cider vinegar (ACV) is a popular home remedy used for managing mild acne, typically applied topically in diluted concentrations of 5 to 10%. Its therapeutic potential stems from its acetic acid content and associated low pH, which may exert antimicrobial effects by creating an inhospitable environment for acne-associated microbes and disrupting microbial membranes.49 Despite its widespread use, ACV lacks clinical trials supporting its efficacy in acne. Furthermore, its acidic nature poses safety concerns. Case reports have documented chemical burns, particularly in children, due to improper or undiluted use. ACV can also enhance the leaching of nickel from metal containers, potentially leading to contact dermatitis in nickel-sensitive individuals.49 Though available OTC and widely accessible, ACV is not FDA-approved for acne treatment.

Discussion

The growing availability of OTC acne treatments reflects a broader shift in dermatologic care, driven by rising antibiotic resistance, cost concerns, breakthroughs in technology, and accessibility barriers. Dermatologists increasingly recommend OTC options as first-line or adjunctive therapies, especially given the limitations of long-term antibiotic use in acne management and the rise of treatment-resistant C. acnes strains.50 OTC products are significantly more affordable and accessible than prescription medications or dermatology appointments. For many patients, particularly those in underserved communities, OTC regimens offer an accessible alternative that avoids long wait times and out of pocket expenses. However, despite this convenience, lack of proper education on OTC product use may pose safety risks. Adverse event reports associated with OTC topical acne products include skin irritation, burning sensation, and dermatitis, highlighting the importance of proper usage and awareness of potential side effects.51 Importantly, while a few ingredients used in OTC acne treatments have either received FDA approval or are recognized under the FDA’s monograph system, the majority of agents have limited or no high-quality clinical evidence supporting their use. Furthermore, although certain ingredients (eg, salicylic acid) are included in the acne monograph, individual products and formulations are not subject to the same level of scrutiny or consistency, contributing to ongoing confusion among consumers and clinicians alike. The rise in novel OTC therapies such as blue light masks, probiotics, and nitric oxide donors further complicates consumer decision-making, as these agents are often marketed with minimal clinical evidence.

In conclusion, although the shift toward OTC acne management presents a valuable opportunity to broaden treatment access, it must be balanced with improved public education, regulatory oversight, and clinician guidance.

Patient consent

Not applicable

Conflicts of interest

YM has no relevant disclosures. PL reports being on the speaker’s bureau for AbbVie, Arcutis, Eli Lilly, Galderma, Hyphens Pharma, Incyte, La Roche-Posay/L’Oréal, Pfizer, Pierre-Fabre Dermatologie, Regeneron/Sanofi Genzyme, Verrica; reports consulting/advisory boards for Alphyn Biologics, AbbVie, Almirall, Amyris, Apogee, Arcutis, ASLAN, Astria Therapeutics, Boston Skin Science, Bristol-Myers Squibb, Burt’s Bees, Castle Biosciences, Codex Labs, Concerto Biosci, Dermavant, Eli Lilly, Galderma, Kenvue, LEO Pharma, Lipidor, L’Oréal, Merck, Micreos, MyOR Diagnostics, Pelthos Therapeutics, Phyla, Regeneron/Sanofi Genzyme, Sibel Health, Skinfix, Soteri Skin, Stratum Biosciences, Sun Pharma, Theraplex, Thimble Health, UCB, Unilever, Verdant Scientific, Verrica, Yobee Care. Stock options with Alphyn Labs, Codex Labs, Concerto Biosci, Soteri Skin, Stratum Biosciences, Thimble, Yobee Care, Verdant Scientific. In addition, Dr. Lio has a patent pending for a Theraplex product with royalties paid and is a Board member and Scientific Advisory Committee Member emeritus of the National Eczema Association.

Funding

None

References
1. Aydemir E. H.. "Acne vulgaris." Turk Pediatri Ars, vol. 49, 2014, p. 13. DOI: 10.5152/tpa.2014.1943.
Google Scholar    PubMed Central    PubMed
2. Tan J.K., Bhate K.. "A global perspective on the epidemiology of acne." Br J Dermatol, vol. 172, 2015, p. 3. DOI: 10.1111/bjd.13462.
Google Scholar    PubMed
4. Gollnick H., Schramm M.. "Topical therapy in acne." J Eur Acad Dermatol Venereol, vol. 11, 1998, p. S8. DOI: 10.1111/j.1468-3083.1998.tb00901.x.
Google Scholar    PubMed
5. Williams A. L., Pace N. D., DeSesso J. M.. "Teratogen update: Topical use and third-generation retinoids." Birth Defects Res, vol. 112, 2020, p. 1105. DOI: 10.1002/bdr2.1745.
Google Scholar    PubMed
6. FDA approves Differin Gel 0.1% for over-the-counter use to treat acne. Accessed May 2, 2025. https://www.fda.gov/news-events/press-announcements/fda-approves-differin-gel-01-over-counter-use-treat-acne
7. Sauer N., Oślizło M., Brzostek M., Wolska J., Lubaszka K., Karłowicz-Bodalska K.. "The multiple uses of azelaic acid in dermatology: mechanism of action, preparations, and potential therapeutic applications." Postepy Dermatol Alergol, vol. 40, 2023, p. 716. DOI: 10.5114/ada.2023.133955.
Google Scholar    PubMed Central    PubMed
8. Application Number: NDA 20-428/S-001-S-007. Accessed May 2, 2025. https://www.accessdata.fda.gov/drugsatfda_docs/nda/96/20428S1S7_Azelex.pdf
9. Sagransky M., Yentzer B. A., Feldman S. R.. "Benzoyl peroxide: a review of its current use in the treatment of acne vulgaris." Expert Opin Pharmacother, vol. 10, 2009, p. 2555. DOI: 10.1517/14656560903277228.
Google Scholar    PubMed
10. Limited number of voluntary recalls initiated after FDA testing of acne products for benzene; findings show a small number of products with elevated levels of benzene contamination. Accessed May 2, 2025. https://www.fda.gov/drugs/drug-safety-and-availability/limited-number-voluntary-recalls-initiated-after-fda-testing-acne-products-benzene-findings-show
11. Bowe W. P., Shalita A. R.. "Effective over-the-counter acne treatments." Semin Cutan Med Surg, vol. 27, 2008, p. 170. DOI: 10.1016/j.sder.2008.07.004.
Google Scholar    PubMed
12. Lu J., Cong T., Wen X., Li X., Du D., He G., Jiang X.. "Salicylic acid treats acne vulgaris by suppressing AMPK/SREBP1 pathway in sebocytes." Exp Dermatol, vol. 28, 2019, p. 786. DOI: 10.1111/exd.13934.
Google Scholar    PubMed
13. Beta hydroxy acids. Accessed May 2, 2025. https://www.fda.gov/cosmetics/cosmetic-ingredients/beta-hydroxy-acids
14. Gupta A.K., Nicol K.. "The use of sulfur in dermatology." J Drugs Dermatol, vol. 3, 2004, p. 427. DOI: .    PubMed
15. Gammoh N. Z., Rink L.. "Zinc in Infection and Inflammation." Nutrients, vol. 9, 2017, p. 624. DOI: 10.3390/nu9060624.
Google Scholar    PubMed Central    PubMed
16. Kurtzweil P.. "Alpha hydroxy acids for skin care." FDA Consum, vol. 32, 1998, p. 30. DOI: 10.1037/e543682006-006.
Google Scholar    PubMed
17. Alpha hydroxy acids. Accessed May 2, 2025. https://www.fda.gov/cosmetics/cosmetic-ingredients/alpha-hydroxy-acids
18. Sinha P., Srivastava S., Mishra N., Yadav N.P.. "New perspectives on antiacne plant drugs: contribution to modern therapeutics." Biomed Res Int, vol. 2014, 2014, p. 301304. DOI: 10.1155/2014/301304.
Google Scholar    PubMed Central    PubMed
20. George C. A., Chhabra N.. "Resorcinol in Dermatology." Indian J Postgrad Dermatol, vol. 2, 2024, p. 20. DOI: 10.25259/IJPGD_108_2023.
Google Scholar
21. Chao C. M., Lai W. Y., Wu B. Y., Chang H. C., Huang W. S., Chen Y. F.. "A pilot study on efficacy treatment of acne vulgaris using a new method: results of a randomized double-blind trial with Acne Dressing." J Cosmet Sci, vol. 57, 2006, p. 95. DOI: .    PubMed
22. Scott A. M., Stehlik P., Clark J., Zhang D., Yang Z., Hoffmann T., Mar C. D., Glasziou P.. "Blue-Light Therapy for Acne Vulgaris: A Systematic Review and Meta-Analysis." Ann Fam Med, vol. 17, 2019, p. 545. DOI: 10.1370/afm.2445.
Google Scholar    PubMed Central    PubMed
23. Carson C. F., Hammer K. A., Riley T. V.. "Melaleuca alternifolia (Tea Tree) oil: a review of antimicrobial and other medicinal properties." Clin Microbiol Rev, vol. 19, 2006, p. 50. DOI: 10.1128/CMR.19.1.50-62.2006.
Google Scholar    PubMed Central    PubMed
24. Fu Y., Zu Y., Chen L., Efferth T., Liang H., Liu Z., Liu W.. "Investigation of antibacterial activity of rosemary essential oil against Propionibacterium acnes with atomic force microscopy." Planta Med, vol. 73, 2007, p. 1275. DOI: 10.1055/s-2007-981614.
Google Scholar    PubMed
25. Miroddi M., Calapai G., Isola S., Minciullo P. L., Gangemi S.. "Rosmarinus officinalis L. as cause of contact dermatitis." Allergol Immunopathol (Madr), vol. 42, 2014, p. 616. DOI: 10.1016/j.aller.2013.04.006.
Google Scholar    PubMed
26. OyetakinWhite P., Tribout H., Baron E.. "Protective mechanisms of green tea polyphenols in skin." Oxid Med Cell Longev, vol. 2012, 2012, p. 560682. DOI: 10.1155/2012/560682.
Google Scholar    PubMed Central    PubMed
27. Yoon J. Y., Kwon H. H., Min S. U., Thiboutot D. M., Suh D. H.. "Epigallocatechin-3-gallate improves acne in humans by modulating intracellular molecular targets and inhibiting P. acnes." J Invest Dermatol, vol. 133, 2013, p. 429. DOI: 10.1038/jid.2012.292.
Google Scholar    PubMed
28. Zhang X., Zhang Z., Tao H., He X., Hsu K., Wang W., Fang X., Steel A.. "Comprehensive assessment of the efficacy and safety of a clay mask in oily and acne skin." Skin Res Technol, vol. 29, 2023, p. e13513. DOI: 10.1111/srt.13513.
Google Scholar    PubMed Central    PubMed
29. Moosavi M.. "Bentonite Clay as a Natural Remedy: A Brief Review." Iran J Public Health, vol. 46, 2017, p. 1176. DOI: .    PubMed Central    PubMed
30. Piazza S., Martinelli G., Vrhovsek U., Masuero D., Fumagalli M., Magnavacca A., Pozzoli C., Canilli L., Terno M., Angarano M., Dell'Agli M., Sangiovanni E.. "Anti-Inflammatory and Anti-Acne Effects of Hamamelis virginiana Bark in Human Keratinocytes." Antioxidants (Basel), vol. 11, 2022, p. 1119. DOI: 10.3390/antiox11061119.
Google Scholar    PubMed Central    PubMed
31. Granlund H.. "Contact allergy to witch hazel." Contact Dermatitis, vol. 31, 1994, p. 195. DOI: 10.1111/j.1600-0536.1994.tb01972.x.
Google Scholar    PubMed
32. Khalil S., Bardawil T., Stephan C., Darwiche N., Abbas O., Kibbi A.G., Nemer G., Kurban M.. "Retinoids: a journey from the molecular structures and mechanisms of action to clinical uses in dermatology and adverse effects." J Dermatolog Treat, vol. 28, 2017, p. 684. DOI: 10.1080/09546634.2017.1309349.
Google Scholar    PubMed
33. Burlando B., Cornara L.. "Honey in dermatology and skin care: a review." J Cosmet Dermatol, vol. 12, 2013, p. 306. DOI: 10.1111/jocd.12058.
Google Scholar    PubMed
34. Zhang T., Sun B., Guo J., Wang M., Cui H., Mao H., Wang B., Yan F.. "Active pharmaceutical ingredient poly(ionic liquid)-based microneedles for the treatment of skin acne infection." Acta Biomater, vol. 115, 2020, p. 136. DOI: 10.1016/j.actbio.2020.08.023.
Google Scholar    PubMed
35. Farfán J., Gonzalez J. M., Vives M.. "The immunomodulatory potential of phage therapy to treat acne: a review on bacterial lysis and immunomodulation." PeerJ, vol. 10, 2022, p. e13553. DOI: 10.7717/peerj.13553.
Google Scholar    PubMed Central    PubMed
36. Qin M., Landriscina A., Rosen J. M., Wei G., Kao S., Olcott W., Agak G. W., Paz K. B., Bonventre J., Clendaniel A., Harper S., Adler B. L., Krausz A. E., Friedman J. M., Nosanchuk J. D., Kim J., Friedman A. J.. "Nitric Oxide-Releasing Nanoparticles Prevent Propionibacterium acnes-Induced Inflammation by Both Clearing the Organism and Inhibiting Microbial Stimulation of the Innate Immune Response." J Invest Dermatol, vol. 135, 2015, p. 2723. DOI: 10.1038/jid.2015.277.
Google Scholar    PubMed Central    PubMed
37. Baldwin H., Blanco D., McKeever C., Paz N., Vasquez Y. N., Quiring J., Enloe C., De León E., Stasko N.. "Results of a Phase 2 Efficacy and Safety Study with SB204, an Investigational Topical Nitric Oxide-releasing Drug for the Treatment of Acne Vulgaris." J Clin Aesthet Dermatol, vol. 9, 2016, p. 12. DOI: .    PubMed Central    PubMed
38. Sheridan R. L., Shank E. S.. "Hyperbaric oxygen treatment: a brief overview of a controversial topic." J Trauma, vol. 47, 1999, p. 426. DOI: 10.1097/00005373-199908000-00045.
Google Scholar    PubMed
39. Gill A. L., Bell C. N.. "Hyperbaric oxygen: its uses, mechanisms of action and outcomes." QJM, vol. 97, 2004, p. 385. DOI: 10.1093/qjmed/hch074.
Google Scholar    PubMed
40. LaMour J., Grimm D., Smith E., Yaniv Z., Hurwitz P.. "Treating Diabetic Peripheral Neuropathy Using a Novel, Nanotechnology-Based Topical Formulation to Improve Pain, Sensitivity, and Function." Int J Diabetes Clin Res, vol. 8, 2021, p. 149. DOI: 10.23937/2377-3634/1410149.
Google Scholar
41. Cogen A. L., Nizet V., Gallo R. L.. "Skin microbiota: a source of disease or defence?." Br J Dermatol, vol. 158, 2008, p. 442. DOI: 10.1111/j.1365-2133.2008.08437.x.
Google Scholar    PubMed Central    PubMed
42. Naik S., Bouladoux N., Wilhelm C., Molloy M. J., Salcedo R., Kastenmuller W., Deming C., Quinones M., Koo L., Conlan S., Spencer S., Hall J. A., Dzutsev A., Kong H., Campbell D. J., Trinchieri G., Segre J. A., Belkaid Y.. "Compartmentalized control of skin immunity by resident commensals." Science, vol. 337, 2012, p. 1115. DOI: 10.1126/science.1225152.
Google Scholar    PubMed Central    PubMed
43. Lee G. R., Maarouf M., Hendricks A. J., Lee D. E., Shi V. Y.. "Topical probiotics: the unknowns behind their rising popularity." Dermatol Online J, vol. 25, 2019, p. . DOI: 10.5070/D3255044062.
Google Scholar    PubMed
44. Dhaliwal S., Rybak I., Ellis S.R., Notay M., Trivedi M., Burney W., Vaughn A.R., Nguyen M., Reiter P., Bosanac S., Yan H., Foolad N., Sivamani R.K.. "Prospective, randomized, double-blind assessment of topical bakuchiol and retinol for facial photoageing." Br J Dermatol, vol. 180, 2019, p. 289. DOI: 10.1111/bjd.16918.
Google Scholar    PubMed
45. Puyana C., Chandan N., Tsoukas M.. "Applications of bakuchiol in dermatology: Systematic review of the literature." J Cosmet Dermatol, vol. 21, 2022, p. 6636. DOI: 10.1111/jocd.15420.
Google Scholar    PubMed
46. Mecha M., Feliú A., Iñigo P. M., Mestre L., Carrillo-Salinas F. J., Guaza C.. "Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: a role for A2A receptors." Neurobiol Dis, vol. 59, 2013, p. 141. DOI: 10.1016/j.nbd.2013.06.016.
Google Scholar    PubMed
47. Peyravian N., Deo S., Daunert S., Jimenez J. J.. "Cannabidiol as a Novel Therapeutic for Immune Modulation." Immunotargets Ther, vol. 9, 2020, p. 131. DOI: 10.2147/ITT.S263690.
Google Scholar    PubMed Central    PubMed
48. Makhakhe L.. "Topical cannabidiol (CBD) in skin pathology - A comprehensive review and prospects for new therapeutic opportunities." S Afr Fam Pract (2004), vol. 64, 2022, p. e1. DOI: 10.4102/safp.v64i1.5493.
Google Scholar    PubMed Central    PubMed
49. Elhage K. G., St Claire K., Daveluy S.. "Acetic acid and the skin: a review of vinegar in dermatology." Int J Dermatol, vol. 61, 2022, p. 804. DOI: 10.1111/ijd.15804.
Google Scholar    PubMed
50. Dessinioti C., Katsambas A.. "Antibiotics and Antimicrobial Resistance in Acne: Epidemiological Trends and Clinical Practice Considerations." Yale J Biol Med, vol. 95, 2022, p. 429. DOI: .    PubMed Central    PubMed
51. Szymanski L., Arekapudi K. L.. "Adverse-Event Reports in Over-the-Counter Topical Acne Drug Products Containing Benzoyl Peroxide from a Specific Pharmaceutical Company in the USA." Dermatol Ther (Heidelb), vol. 12, 2022, p. 2397. DOI: 10.1007/s13555-022-00808-9.
Google Scholar    PubMed Central    PubMed
21
Downloads
38
Total Views
Article impact
Share
Cite
Article Info
DOI:
10.64550/joid.2gybwa46
Reviewed by:
Jennifer Ornelas, MD, Natalie Yin, MD
View PDF
Citation
Cite as
[1]
“Beyond Benzoyl Peroxide: The New Landscape of Over-the-counter Therapies for Acne: Once limited to benzoyl peroxide and salicylic acid, over-the-counter acne treatments now span probiotics, light therapy, and botanical agents, expanding options but raising questions about evidence, safety, and regulation”., JOID, vol. 1, no. 1, Nov. 2025, doi: 10.64550/joid.2gybwa46.
Export citation
Select the format you want to export the citation of this publication.
Download Citation
Export Citation